[Cost reduction in drug therapy of diabetes]

The costs of control an therapy of diabetes mellitus are very expensive. A cost reduction is to be expected after successful therapy. For 1024 insulin dependent type I-diabetics with stable insulin requirements the mean costs remained unchanged. 456 insulin dependent type II-diabetics who reduced weight showed a slight reduction of mean costs. The cost of drug therapy were significantly reduced for 535 overweight type II-diabetics under different therapeutic modalities, who reached a weight reduction. The inpatient treatment of diabetes influences the costs of drug therapy. A cost reduction is to be expected for overweight type II-diabetics, who can reach a weight reduction.